Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 11/20 | 0.80 |
| ▸ | HTR1A | P08908 | 4/20 | 0.80 |
| ▸ | DRD2 | P14416 | 4/20 | 0.80 |
| ▸ | DRD4 | P21917 | 4/20 | 0.80 |
| ▸ | DRD5 | P21918 | 4/20 | 0.80 |
| ▸ | HTR1D | P28221 | 4/20 | 0.80 |
| ▸ | HTR1E | P28566 | 4/20 | 0.80 |
| ▸ | HTR7 | P34969 | 4/20 | 0.80 |
| ▸ | HRH1 | P35367 | 4/20 | 0.80 |
| ▸ | DRD3 | P35462 | 4/20 | 0.80 |
| ▸ | HTR2B | P41595 | 4/20 | 0.80 |
| ▸ | HTR5A | P47898 | 4/20 | 0.80 |
| ▸ | HTR6 | P50406 | 4/20 | 0.80 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.80 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.80 |
| ▸ | HTR2C | P28335 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | USP2 | O75604 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30886877 | 1.00 | HTR2A (0.80) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL9853854 | 0.91 | HTR2A (0.76) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL9853852 | 0.91 | HTR2A (0.76) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL25545441 | 0.90 | HTR2A (0.75) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL20970957 | 0.90 | HTR2A (0.75) | HTR2AHTR1ADRD2DRD4DRD5 | |
| Hydrochloric Acid SCHEMBL9853861 | 0.90 | HTR2A (0.75) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL29556873 | 0.90 | HTR2A (0.75) | HTR2AHTR1ADRD2DRD4DRD5 | |
| SCHEMBL28377126 | 0.90 | HTR2A (0.77) | HTR2AHTR1ADRD2DRD4DRD5 | |
| Hydrochloric Acid SCHEMBL32667423 | 0.89 | HTR2A (0.73) | HTR2AHTR1ADRD2DRD4DRD5 | |
| Lysergide SCHEMBL28202464 | 0.89 | HTR2A (0.96) | HTR2AHTR1ADRD2DRD4DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108493-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | CAAMTECH, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260092034-A1 | 7-AZAINDOLE ANALOGS AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING THE SAME | KULEON LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260083759-A1 | Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders | HADASIT MED RES SERVICE (IL) | 2026-03-26 | — | — | US | disclosed |
| US-12570602-B2 | Selective serotonin receptor modulators and methods of making and using the same | Park City Bio, LLC (US) | 2026-03-10 | — | — | US | disclosed |
| US-12564560-B1 | Selective serotonin receptor modulators and methods of making and using the same | Park City Bio, LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250376436-A1 | Selective Serotonin Receptor Modulators and Methods of Making and Using the Same | Park City Bio, LLC (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250340513-A1 | NEUROPLASTOGENS AND NON-HALLUCINOGENIC SEROTONIN 5-HT2A/2C RECEPTOR MODULATORS | KULEON LLC (US) | 2025-11-06 | — | — | US | disclosed |
| US-12441683-B2 | 7-methyl indole analogs and dosage forms containing the same | Kuleon, LLC (US) | 2025-10-14 | — | — | US | disclosed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-20250289817-A1 | SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | KULEON LLC (US) | 2025-09-18 | — | — | US | disclosed |
| WO-2022079574-A1 | COMPOSITIONS FOR REDUCING INFLAMMATION TO IMPROVE OR MAINTAIN MENTAL OR PHYSICAL HEALTH | GOODCAP PHARMACEUTICALS LTD. (CA) | 2022-04-21 | — | — | WO | disclosed |
| US-20210361679-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | CAAMTECH, INC. (US) | 2021-11-25 | — | — | US | disclosed |
| US-20210346346-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | CAAMTECH, INC. (US) | 2021-11-11 | — | — | US | disclosed |
| US-20190142851-A1 | COMPOSITIONS COMPRISING A PSILOCYBIN DERIVATIVE AND A CANNABINOID | CAAMTECH, INC. | 2019-05-16 | — | — | US | disclosed |
| US-20110257628-A1 | INSTRUMENT FOR ALLEVIATING ADDICTIVE DRUG CRAVING, METHOD FOR USING SAME AND METHOD FOR TREATING ADDICTIVE DRUG DEPENDENCE | HIRAI SHINJI | 2011-10-20 | — | — | US | disclosed |
| EP-2371340-A1 | INSTRUMENT FOR ALLEVIATING ADDICTIVE DRUG CRAVING, METHOD FOR USING SAME AND METHOD FOR TREATING ADDICTIVE DRUG DEPENDENCE | Hirai, Shinji (JP) | 2011-10-05 | — | — | EP | disclosed |
| WO-2007128409-A1 | INSECTICIDAL DESPYRROLE ANALOGS OF LISURIDE AND LYSERGAMIDES | BAYER CROPSCIENCE AG (DE) | 2007-11-15 | — | — | WO | disclosed |
| CN-1059210-C | Process for preparing 6-heterocyclic-4-amino-1, 3,4, 5-tetrahydrobenz [ cd ] indoles and their pharmaceutically acceptable acid addition salts | LILLY CO ELI (US) | 2000-12-06 | — | — | CN | disclosed |
| CN-1268352-A | Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole | LILLY CO ELI (US) | 2000-10-04 | — | — | CN | disclosed |
| CN-1066072-A | 6-heterocyclic-4-amino-1, 3, 4, 5-tetrahydrobenzo [ cd ] indoles | LILLY CO ELI (US) | 1992-11-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190142851-A1 | COMPOSITIONS COMPRISING A PSILOCYBIN DERIVATIVE AND A CANNABINOID | CNR1, CNR2, HTR5A | HTR2A 6/4885HTR1A 5/4885DRD2 32/4885 |
| US-20250376436-A1 | Selective Serotonin Receptor Modulators and Methods of Making and Using the Same | HTR1A, HTR4, HTR5A | HTR2A 8/4885HTR1A 1/4885DRD2 65/4885 |
| US-20260092034-A1 | 7-AZAINDOLE ANALOGS AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING THE SAME | HTR2C, HTR7, HTR6 | HTR2A 6/4885HTR1A 5/4885DRD2 38/4885 |
| US-20250289817-A1 | SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | HTR5A, HTR1A, HTR3A | HTR2A 5/4885HTR1A 2/4885DRD2 143/4885 |
| US-20210346346-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | HTR3A, HTR2A, HTR5A | HTR2A 2/4885HTR1A 5/4885DRD2 44/4885 |
| US-20260083759-A1 | Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders | BDNF, NTRK2, GRIN2A | HTR2A 33/4885HTR1A 34/4885DRD2 32/4885 |
| US-12441683-B2 | 7-methyl indole analogs and dosage forms containing the same | HTR7, HTR2C, HTR1A | HTR2A 8/4885HTR1A 3/4885DRD2 50/4885 |
| US-20260108493-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | ADRA2C, ADRB3, ADRA2B | HTR2A 19/4885HTR1A 22/4885DRD2 60/4885 |
| US-20250340513-A1 | NEUROPLASTOGENS AND NON-HALLUCINOGENIC SEROTONIN 5-HT2A/2C RECEPTOR MODULATORS | HTR2A, HTR2C, HTR3A | HTR2A 1/4885HTR1A 4/4885DRD2 55/4885 |
| US-20210361679-A1 | COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND | HTR3A, HTR2A, HTR5A | HTR2A 2/4885HTR1A 5/4885DRD2 44/4885 |
| US-12570602-B2 | Selective serotonin receptor modulators and methods of making and using the same | HTR1D, HTR1A, HTR4 | HTR2A 14/4885HTR1A 2/4885DRD2 51/4885 |
| US-12564560-B1 | Selective serotonin receptor modulators and methods of making and using the same | HTR5A, HTR1A, HTR1D | HTR2A 16/4885HTR1A 2/4885DRD2 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.